Cardiopulmonary Bypass Completed Phase 4 Trials for Ulinastatin (DB12038)

Also known as: Cardiopulmonary bypass / Bypass, Cardiopulmonary

IndicationStatusPhase
DBCOND0032101 (Cardiopulmonary Bypass)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03154814Ulinastatin Improves Postoperative Oxygenation After Cardiopulmonary BypassTreatment